• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Enhabit Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events

    5/12/26 1:33:43 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email
    ehab-20260512
    false000180373700018037372026-05-122026-05-12

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
    Date of Report (date of earliest event reported): May 12, 2026
    Enhabit, Inc.
    (Exact name of registrant as specified in its charter)

    Delaware001-4140647-2409192
    (State or other jurisdiction (Commission(IRS Employer
    of incorporation) File Number) Identification No.)

    6688 N. Central Expressway, Suite 1300, Dallas, Texas 75206
    (Address of principal executive offices, including zip code)
    (214) 239-6500
    (Registrant’s telephone number, including area code)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per shareEHABNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
        Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 5.07 Submission of Matters to a Vote of Security Holders.
    At a special meeting of stockholders of Enhabit, Inc., a Delaware corporation (the “Company”), held on May 12, 2026 (the “Special Meeting”), the Company’s stockholders voted to adopt the Agreement and Plan of Merger, dated as of February 22, 2026 (the “Merger Agreement”), by and among the Company, Anchor Parent, LLC, a Delaware limited liability company (“Parent”), and Anchor Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.
    As of the close of business on April 13, 2026, the record date for the Special Meeting (the “Record Date”), there were 51,225,606 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), issued and outstanding and entitled to vote at the Special Meeting, with each such share entitled to one vote. At the Special Meeting, the holders of a total of 36,341,102 shares (approximately 71%) of Common Stock were present or represented by proxy, constituting a quorum.
    At the Special Meeting, the Company’s stockholders considered (i) a proposal to adopt the Merger Agreement (the “Merger Proposal”) and (ii) a proposal to approve, on a non-binding, advisory basis, a resolution on certain compensation that may be paid or become payable to the Company’s named executive officers that is based on or otherwise relates to the Merger (the “Compensation Proposal”). The proposal to approve the adjournment or postponement of the Special Meeting to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there were insufficient votes to approve the Merger Proposal at the time of the Special Meeting, was not voted on at the Special Meeting because there were sufficient votes to approve the Merger Proposal at the Special Meeting. A more complete description of each proposal is set forth in the Company’s definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission (the “SEC”) on April 14, 2026.
    The number of votes cast for or against as well as abstentions, as applicable, with respect to each matter is set forth below.
    Proposal 1. The Merger Proposal
    Approval of the Merger Proposal required the affirmative vote of the majority of the voting power of the issued and outstanding shares of Common Stock as of the close of business on the Record Date.
    The Merger Proposal was approved with the following vote:
    Votes For Votes AgainstVotes Abstained
    36,311,91018,27510,917
    Proposal 2. The Compensation Proposal
    Approval of the Compensation Proposal required the affirmative vote of the majority of the outstanding shares of Common Stock as of the close of business on the Record Date entitled to vote on the Compensation Proposal and present or represented by proxy at the Special Meeting.
    The Compensation Proposal was approved with the following vote:
    Votes For Votes AgainstVotes Abstained
    33,086,2103,030,210224,682
    Item 8.01 Other Events.
    Following receipt of the approval of the Merger Proposal, the parties intend to complete the Merger on May 15, 2026. Completion of the Merger remains subject to the satisfaction or waiver of customary closing conditions set forth in the Merger Agreement that by their nature are to be satisfied at the closing of the Merger. Following the Merger, the Common Stock will be delisted from the New York Stock Exchange and shares of the Common Stock will cease to be publicly traded.



    Forward-Looking Statements
    This Current Report on Form 8-K contains and the Company’s other filings and press releases may contain forward-looking statements, which include all statements that do not relate solely to historical or current facts, such as statements regarding the Company’s expectations, intentions or strategies regarding the future. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “aim,” “potential,” “continue,” “ongoing,” “goal,” “can,” “seek,” “target” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements are based on Company management’s current beliefs, as well as assumptions made by, and information currently available to, the Company, all of which are subject to change. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected and are subject to a number of known and unknown risks and uncertainties, including: (i) the risk that the proposed Merger may not be completed in a timely manner or at all, which may adversely affect the Company’s business and the price of the Common Stock; (ii) the occurrence of any fact, event, change, development or circumstance that could give rise to the termination of the Merger Agreement, including in circumstances requiring the Company to pay a termination fee; (iii) the effect of the announcement or pendency of the proposed Merger on the Company’s business relationships, operating results and business generally; (iv) risks that the proposed Merger disrupts the Company’s current plans and operations; (v) the Company’s ability to retain and hire key personnel and maintain relationships with key business partners and customers, and others with whom it does business, in light of the proposed Merger; (vi) risks related to the diversion of management’s attention from the Company’s ongoing business operations; (vii) unexpected costs, charges or expenses resulting from the proposed Merger; (viii) the ability of Parent to obtain financing for the proposed Merger; (ix) litigation relating to the proposed Merger that has and could be instituted against the parties to the Merger Agreement or their respective directors, managers or officers, including the effects of any outcomes related thereto; (x) continued availability of capital and financing; (xi) certain restrictions during the pendency of the proposed Merger that may impact the Company’s ability to pursue certain business opportunities or strategic transactions; and (xii) other risks described in the Company’s filings with the SEC, such risks and uncertainties described under the headings “Cautionary Note Regarding Forward-Looking Statements,” “Risk Factors” and other sections of the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2026 and subsequent filings. No list or discussion of risks or uncertainties should be considered a complete statement of all potential risks and uncertainties. Unlisted or unknown factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, and legal liability to third parties and similar risks, any of which could have a material adverse effect on the completion of the proposed Merger and/or the Company’s consolidated financial condition, results of operations or liquidity. The forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to provide revisions or updates to any forward-looking statements, whether as a result of new information, future events or otherwise, should circumstances change, except as otherwise required by law.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
    ENHABIT, INC.
    By:/s/ Dylan C. Black
    Name:Dylan C. Black
    Title:General Counsel
    Dated: May 12, 2026

    Get the next $EHAB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    3/6/2026$13.80Buy → Hold
    TD Cowen
    1/22/2026$14.00Perform → Outperform
    Oppenheimer
    1/13/2026$12.00Hold → Buy
    TD Cowen
    1/8/2026$12.00Neutral → Buy
    UBS
    1/7/2026$10.50Hold
    Truist
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    More analyst ratings

    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Solomon Ryan bought $76,400 worth of shares (10,000 units at $7.64), increasing direct ownership by 5% to 193,468 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    8/11/25 6:30:04 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/12/24 5:01:19 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    12/11/24 5:56:33 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook

    Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders (the "Special Meeting") on May 12, 2026, at 8 a.m. CDT, to vote on the previously announced agreement and plan of merger (the "Merger Agreement"). Pursuant to the Merger Agreement, Anchor Merger Sub, Inc., a Delaware corporation ("Merger Sub") and a wholly owned subsidiary of Anchor Parent, LLC ("Parent"), will be merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Parent and Merger Sub are affiliates of funds advised by Kinderhook Industries, L

    4/16/26 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit to be Acquired by Kinderhook Industries

    Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC ("Kinderhook"), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the Company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the Compan

    2/23/26 8:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    SEC Filings

    View All

    SEC Form 15-12G filed by Enhabit Inc.

    15-12G - Enhabit, Inc. (0001803737) (Filer)

    5/26/26 9:36:26 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form S-8 POS filed by Enhabit Inc.

    S-8 POS - Enhabit, Inc. (0001803737) (Filer)

    5/15/26 2:10:50 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form S-8 POS filed by Enhabit Inc.

    S-8 POS - Enhabit, Inc. (0001803737) (Filer)

    5/15/26 2:10:36 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Jacobsmeyer Barbara Ann returned $16,704,541 worth of shares to the company (1,210,474 units at $13.80) and was granted 603,767 shares, closing all direct ownership in the company (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    5/15/26 12:42:41 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    General Counsel and Secretary Black Dylan C returned $2,869,144 worth of shares to the company (207,909 units at $13.80) and was granted 108,086 shares, closing all direct ownership in the company (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    5/15/26 12:41:40 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    EVP of Home Health Operations Jolley Julie Diane returned $3,678,238 worth of shares to the company (266,539 units at $13.80) and was granted 129,409 shares, closing all direct ownership in the company (SEC Form 4)

    4 - Enhabit, Inc. (0001803737) (Issuer)

    5/15/26 12:40:43 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enhabit Inc. downgraded by TD Cowen with a new price target

    TD Cowen downgraded Enhabit Inc. from Buy to Hold and set a new price target of $13.80

    3/6/26 8:25:46 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Enhabit Inc. from Perform to Outperform and set a new price target of $14.00

    1/22/26 8:46:17 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Inc. upgraded by TD Cowen with a new price target

    TD Cowen upgraded Enhabit Inc. from Hold to Buy and set a new price target of $12.00

    1/13/26 8:41:29 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Leadership Updates

    Live Leadership Updates

    View All

    Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners

    On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court

    12/4/24 8:30:00 AM ET
    $EHAB
    $EHC
    Medical/Nursing Services
    Health Care
    Hospital/Nursing Management

    Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

    Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl

    11/7/24 7:30:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    American Water Appoints New Independent Member to the Board of Directors

    American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan

    10/30/24 4:46:00 PM ET
    $AWK
    $EHAB
    Water Supply
    Utilities
    Medical/Nursing Services
    Health Care

    $EHAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Enhabit Inc.

    SC 13G - Enhabit, Inc. (0001803737) (Subject)

    11/14/24 9:12:39 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Enhabit Inc.

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    10/4/24 1:56:05 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Enhabit Inc. (Amendment)

    SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

    2/13/24 5:04:31 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    $EHAB
    Financials

    Live finance-specific insights

    View All

    Enhabit Sets Stockholder Meeting Date of May 12, 2026, to Approve Transaction with Kinderhook

    Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that it will hold the special meeting of stockholders (the "Special Meeting") on May 12, 2026, at 8 a.m. CDT, to vote on the previously announced agreement and plan of merger (the "Merger Agreement"). Pursuant to the Merger Agreement, Anchor Merger Sub, Inc., a Delaware corporation ("Merger Sub") and a wholly owned subsidiary of Anchor Parent, LLC ("Parent"), will be merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Parent and Merger Sub are affiliates of funds advised by Kinderhook Industries, L

    4/16/26 4:15:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit Reports Fourth Quarter 2025 Financial Results

    Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2025. "Our fourth quarter 2025 results capped a pivotal year for Enhabit, delivering an emerging growth story with year over year increases in patient census, revenue and Adjusted EBITDA," said Barb Jacobsmeyer, CEO and president of Enhabit. "The consistent execution of our strategy throughout the year materially improved free cash flow, enabling us to further strengthen our balance sheet, positioning us well to accelerate growth and investment in 2026." QUARTERLY PERFORMANCE - CONSOLIDATED Net service revenue of $270.4 million

    3/4/26 4:10:00 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care

    Enhabit to be Acquired by Kinderhook Industries

    Enhabit, Inc. Stockholders to Receive $13.80 per Share in Cash Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it has entered into a definitive agreement to be acquired by Kinderhook Industries, LLC ("Kinderhook"), a middle market private equity firm, in an all-cash transaction for a total enterprise value of approximately $1.1 billion. Under the terms of the agreement, Enhabit stockholders will receive $13.80 per share in cash, which represents a premium of approximately 24.4% to the Company's closing stock price on February 20, 2026, the last full trading day prior to the announcement of the transaction, and a 33.8% premium to the Compan

    2/23/26 8:00:00 AM ET
    $EHAB
    Medical/Nursing Services
    Health Care